Trial Profile

A Phase III HEEALING 2 study to evaluate maintenance therapy of linaprazan glurate in patients with Erosive Gastroesophageal Reflux Disease (GERD).

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 30 Oct 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

30 Oct 2025 New trial record
07 Oct 2025 According to the Cinclus Pharma Media Release, this trial is planned to evaluate maintenance therapy, is planned to commence in both the US and Europe following the topline results of HEEALING 1.
29 Aug 2025 According to the Cinclus Pharma Media Release, company plans to extend development to the US through the second healing study, HEEALING 2, which will also evaluate maintenance therapy. This study is expected to begin as planned following the topline results of HEEALING 1.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com